Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder.
Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder.
复制标题
皮质醇对地西泮的反应：其与年龄、剂量、治疗持续时间和广泛性焦虑症的存在的关系。
DOI：
10.1007/s00213-004-1974-8
复制
发表时间：
2005
影响因子：
3.4
通讯作者：
Greenblatt,DavidJ
中科院分区：
文献类型：
--
作者：
Pomara,Nunzio;Willoughby,LisaM;Sidtis,JohnJ;Cooper,ThomasB;Greenblatt,DavidJ
ObjectiveAcute diazepam administration has been shown to decrease plasma cortisol levels consistent with decreased activity of the hypothalamic-pituitary-adrenal axis, especially in individuals experiencing stress. However, the effects of chronic diazepam treatment on cortisol have been less studied, and the relationship to age, anxiety, duration of treatment, and dose are not well understood.MethodThis double-blind placebo-controlled study examined acute and chronic effects of diazepam on plasma cortisol levels in young (19–35 years) and elderly (60–79 years) individuals with and without generalized anxiety disorder (GAD). Subjects received single oral challenges of placebo or diazepam (2.5 mg or 10 mg) in a placebo-controlled cross-over design, followed by 3 weeks of chronic daily treatment with 2.5 mg or 10 mg diazepam or placebo taken at 10 p.m., and then by a final acute challenge with a single oral dose of the same study medication received during chronic treatment.ResultsThe elderly experienced significant reductions in plasma cortisol levels compared to placebo both in the initial challenge and during chronic treatment, but the young did not. However, cortisol response to drug was comparable in both groups. Final challenge did not produce any significant cortisol effects in either group and the cortisol response in the elderly was significantly reduced compared to the initial challenge. GAD status was not a factor in plasma cortisol responses to diazepam.ConclusionsDiazepam reduced cortisol both acutely and during chronic treatment, but not during final challenge, consistent with some tolerance development. This effect was most apparent in the elderly compared with the young adults and was not modulated by GAD status or dosage, and was not related to drug effects on performance and on self-ratings of sedation and tension.
